DrugPatentWatch Database Preview
Litigation Details for Millennium Pharmaceuticals Inc. v. Accord Healthcare Inc. (D. Del. 2012)
» See Plans and Pricing
Millennium Pharmaceuticals Inc. v. Accord Healthcare Inc. (D. Del. 2012)
| Docket | Start Trial | Date Filed | 2012-11-19 |
| Court | District Court, D. Delaware | Date Terminated | 2015-09-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,713,446; 6,958,319 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Millennium Pharmaceuticals Inc. v. Accord Healthcare Inc.
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for Millennium Pharmaceuticals Inc. v. Accord Healthcare Inc. (D. Del. 2012)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2012-11-19 | 1 | BACKGROUND l7. United States Patent No. 6,713,446 (“the ’446 patent”), entitled “Formulation of Boronic…VELCADE® prior to the expiration of U.S. Patent Nos. 6,713,446 and 6,958,319. DLIES 2. Plaintiff Millennium…the Notice Letter. M INFRINGEMENT oF U.s. PATENT No. 6.713,446 28. Plaintiff incorporates each of the … ACTION l. This is an action for patent infringement under the patent laws of the United States, Title…January 25, 2022. 18. United States Patent No. 6,958,319 (“the ’319 patent”), entitled “Formulation of Boronic | External link to document | |
| 2012-11-19 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2; 6,958,319 B2;. … 24 September 2015 1:12-cv-01490 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
